Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06406777 · ClinicalTrials.gov registry record · Phase 1
Chronic Lung Allograft Dysfunction MRI Study
A Phase 1 study of Chronic Lung Allograft Dysfunction Lung MRI (CLAD), sponsored by Sean Fain.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06406777 is a Phase 1 study of Chronic Lung Allograft Dysfunction Lung MRI (CLAD) that is actively recruiting participants, run by Sean Fain. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06406777, a Phase 1 study of Chronic Lung Allograft Dysfunction Lung MRI (CLAD), is actively recruiting participants, sponsored by Sean Fain.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this will enhance understanding of CLAD pathophysiology. Moreover, this project is foundational to performing additional studies to establish if novel MRI imaging can serve as an objective confirmatory diagnostic tool for CLAD in post-transplant patients.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Spirometry
- DIAGNOSTIC_TEST Contrast Lung Computed Tomography (CT) Scan
- DIAGNOSTIC_TEST Oxygen enhanced magnetic resonance imaging (OE-MRI) Scan
- DRUG 129Xe MRI scans
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-03-20 |
| Est. Completion | 2028-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06406777
The ClinicalTrials.gov registry entry for NCT06406777 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sean Fain, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Lung Allograft Dysfunction Lung MRI (CLAD) appearing as the primary indexed condition, and to 4 interventions - of which Spirometry is the first listed.
NCT06406777 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT06406777 about?
NCT06406777 is a clinical study titled "Chronic Lung Allograft Dysfunction MRI Study". This studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this will enhance understanding of CLAD pathophysiology. Moreover, this project is foundational to performing additional studies to establish if n...
What is the current status of trial NCT06406777?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2025-03-20. Estimated completion is 2028-09.
What conditions does trial NCT06406777 study?
This clinical trial studies the following conditions: Chronic Lung Allograft Dysfunction Lung MRI (CLAD).
What interventions are being tested in trial NCT06406777?
The interventions under investigation include: Spirometry (DIAGNOSTIC_TEST), Contrast Lung Computed Tomography (CT) Scan (DIAGNOSTIC_TEST), Oxygen enhanced magnetic resonance imaging (OE-MRI) Scan (DIAGNOSTIC_TEST), 129Xe MRI scans (DRUG).
Who is sponsoring clinical trial NCT06406777?
This trial is sponsored by Sean Fain, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06406777 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.